<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Aguilar, David</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Managing Patients with Heart Failure and Diabetes</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">35-36</style></pages><abstract><style  face="normal" font="default" size="100%">It is currently estimated that 5.1 million adults in the United States have heart failure (HF). By the year 2030, this number is expected to increase by 25%. Over the last several decades, there has also been a marked increase in the prevalence of diabetes [Centers for Disease Control and Prevention. Available at http://www.cdc.gov/diabetes/statistics]. This article discusses the relationship between and coexistence of these two diseases including whether the presence of diabetes should influence the management of patients with HF, and diabetic cardiac dysfunction—lipotoxic cardiomyopathy.</style></abstract><number><style face="normal" font="default" size="100%">20</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>